Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke

American Journal of Respiratory and Critical Care Medicine - Tập 172 Số 7 - Trang 848-853 - 2005
P. A. Martorana1, Rolf Beume1, Monica Lucattelli1, Lutz Wollin1, Giuseppe Lungarella1
1Department of Physiopathology and Experimental Medicine, University of Siena, Siena, Italy; and ALTANA Pharma, Konstanz, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(96)07492-2

10.1081/COPD-120030163

10.1164/ajrccm.153.2.8564146

10.1164/ajrccm.160.5.9811058

10.1053/rmed.2000.0960

10.1183/09031936.01.99086801

Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid action in alveolar macrophages. FASEB J 2001;15:1100–1102.

10.1067/mai.2002.120525

10.1016/S0165-6147(97)01049-3

10.1152/ajplung.2001.281.2.L412

10.1164/ajrccm.164.5.2010032

10.1164/rccm.200212-1396OC

10.1164/rccm.200302-203OC

Martorana PA, Beume R, Lucattelli M, Wollin L, Lungarella G. Roflumilast, a targeted phosphodiesterase 4 inhibitor, fully prevents the development of emphysema induced by cigarette smoke exposure in mice [abstract]. Am J Respir Crit Care Med 2005;2:A543.

10.1002/1097-0320(20010901)45:1<27::AID-CYTO1141>3.0.CO;2-I

Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis 1967;95:752–764.

Thurlbeck WM. Internal surface area of non emphysematous lungs. Am Rev Respir Dis 1967;95:765–773.

Pack RJ, Al-Ugaily LH, Morris G. The cells of the tracheobronchial epithelium of the mouse: a quantitative light and electron microscope study. J Anat 1981;132:71–84.

10.1016/0378-4347(95)00092-W

10.1046/j.1365-2222.1999.00018.x

Giembycz MA. Development status of second generation of PDE4 inhibitors for asthma and COPD: the story so far. Monaldi Arch Chest Dis 2002;57:48–64.

Hatzelmann A, Schudt C. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J Pharmacol Exp Ther 2001;297:267–279.

Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, Beume R. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J Pharmacol Exp Ther 2001;297:280–290.

Wollin L, Barsig J, Marx D, Beume R. Inhibition by roflumilast vs cilomilast of pulmonary leukocyte accumulation and TNFα release in a rat model of LPS-induced pulmonary neutrophilia [abstract]. Eur Respir J 2003;22:107s.

Hacham M, White RM, Argov S, Segal S, Apte RN. Interleukin-6 and interleukin-10 are expressed in organs of normal young and old mice. Eur Cytokine Netw 2004;15:37–46.

10.1111/j.1472-8206.1999.tb00326.x

10.1164/rccm.2211009

10.1165/rcmb.4791

10.1164/rccm.200404-511OC

10.1016/S0002-9440(10)63589-4

10.1165/rcmb.4818

Fox JC, Spicer D, Henning R, Meshi B, Shrad MT, Hogg JC, Fitzgerald MF. Efficacy of the PDE4 inhibitor, BAY 19-8004, in tobacco smoke models of COPD in the guinea pig [abstract]. Am J Respir Crit Care Med 2003;167:A91.

Fitzgerald MF, Spicer D, Henning R. Efficacy of the PDE4 inhibitor, BAY 19-8004 and a steroid in tobacco smoke-induced models of pulmonary inflammation in the mouse [abstract]. Am J Respir Crit Care Med 2003;167:A91.

10.1183/09031936.04.00067204

Wollin L, Bundschuh DS, Ostermann A, Barsig J, Marx D, Wohlsen A, Beume R. Inhibition of asthma key mediators and inflammation by roflumilast: effects on the time course in OVA-challenged Brown Norway rats [abstract]. Am J Respir Crit Care Med 2004;169:A803.